Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
Personalized oral dosing plan with specific timing, frequency, and duration tailored to your digestive concerns and therapeutic goals
What about a B12 detox or toxin release
When you come in for a consultation at ChiroHer, we'll take a thorough approach to understand your needs
It is important in the maintenance of our metabolism, blood cells, and nerve function
The dose might change based on how severe the deficiency is
US$ 25.63
US$ 26.75
US$ 20.30
US$ 20.28
US$ 24.84
